December 05, 2025

On the Edge of a Measles Comeback?

New analysis examines rising U.S. measles outbreaks, associated clinical risks, and the potential loss of measles-elimination status.

KFF Health News

December 02, 2025

Top 10 States to Practice Neurology

The following list highlights the states that offer the most favorable conditions for neurologists.

Conexiant

November 25, 2025

Brain Shifts at Hidden Ages 

Manifold analysis reveals distinct organizational epochs separated by turning points at ages 9, 32, 66, and 83 years across 4,216 diffusion imaging scans.

Conexiant

November 14, 2025

Epilepsy Trends: Do Long-Term Outcomes Improve?

Researchers found seizure reductions over time in patients with focal treatment-resistant epilepsy.

Conexiant

November 12, 2025

AVM Hemorrhage Risk: Is It Time to Rethink the Data?

Researchers redefine the true hemorrhage risk of unruptured brain arteriovenous malformations.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

May 09, 2024

Time of Day May Impact Aging Predictions

New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.

Conexiant

April 28, 2025

One Third Report HPPD After Psychedelics

Delusional ideation was found to be reduced one month after psychedelic use, researchers reported in a prospective cohort of 654 participants.

Conexiant